首页> 外文期刊>Human Molecular Genetics >SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein.
【24h】

SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein.

机译:SCA17,一种新型的常染色体显性小脑共济失调,由TATA结合蛋白中的聚谷氨酰胺扩展引起。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Genetic etiologies of at least 20% of autosomal dominant cerebellar ataxias (ADCAs) have yet to be clarified. We identified a novel spinocerebellar ataxia (SCA) form in four Japanese pedigrees which is caused by an abnormal CAG expansion in the TATA-binding protein (TBP) gene, a general transcription initiation factor. Consequently, it has been added to the group of polyglutamine diseases. This abnormal expansion of glutamine tracts in TBP bears 47--55 repeats, whereas the normal repeat number ranges from 29 to 42. Immunocytochemical examination of a postmortem brain which carried 48 CAG repeats detected neuronal intranuclear inclusion bodies that stained with anti-ubiquitin antibody, anti-TBP antibody and with the 1C2 antibody that recognizes specifically expanded pathological polyglutamine tracts. We therefore propose that this new disease be called SCA17 (TBP disease).
机译:至少20%的常染色体显性小脑共济失调(ADCA)的遗传病因尚未阐明。我们在四个日本谱系中确定了一种新型的脊髓小脑共济失调(SCA)形式,这是由TATA结合蛋白(TBP)基因(一种一般的转录起始因子)中的CAG扩增异常引起的。因此,它已被添加到多谷氨酰胺疾病中。 TBP中谷氨酰胺束的这种异常扩增带有47--55个重复序列,而正常重复序列的范围是29至42个。进行48个CAG重复序列的死后大脑的免疫细胞化学检查发现神经元核内包涵体被抗泛素抗体染色,抗TBP抗体和1C2抗体,可识别特异扩展的病理性聚谷氨酰胺束。因此,我们建议将该新疾病称为SCA17(TBP疾病)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号